RecruitingNCT06211569

Study of the Prevalence of Endometriosis and Adenomyosis

Study of the Prevalence of Endometriosis and Adenomyosis in Women of Childbearing Age Consulting for Non-medical Oocyte Self-preservation

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

400 participants

Start Date

Apr 4, 2024

Study Type

OBSERVATIONAL

Conditions

Elective Fertility Preservation

Summary

Our study aims to assess the prevalence of adenomyosis and endometriosis in patients consulting for elective fertility preservation through the diagnosis of these pathologies by transvaginal pelvic ultrasound. Imaging data will be compared with clinical data (patient characteristics, clinical symptoms) as well as the assessment of anxiety, depression, and quality of life collected from the women.

Eligibility

Sex: FEMALEMin Age: 29 YearsMax Age: 37 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Usual follow-up for people with elective fertility preservation. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 29 Years to 37 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERUsual follow-up

Usual follow-up

Locations(1)

Gynécologie Obstétrique II et médecine de la reproduction, Hôpital Cochin, Port Royal

Paris, Île-de-France Region, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06211569